Groupama Asset Managment Halozyme Therapeutics, Inc. Transaction History
Groupama Asset Managment
- $5.01 Trillion
- Q1 2025
A detailed history of Groupama Asset Managment transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Groupama Asset Managment holds 1,200,000 shares of HALO stock, worth $74.8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,200,000
Previous 1,200,000
-0.0%
Holding current value
$74.8 Million
Previous $1.3 Billion
18.38%
% of portfolio
0.03%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
584Shares Held
122MCall Options Held
308KPut Options Held
186K-
Black Rock Inc. New York, NY17.6MShares$1.1 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$800 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$377 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$243 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$229 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.68B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...